Quantitative Measurement of Serum Calcium, Iron, Cholesterol and Triglycerides and their Relationships with Cardiac Diseases among the Peoples in Manipur: India
Authors/Creators
- 1. Senior Resident, Department of Biochemistry, Shija Academy of Health Sciences, Manipur, India
- 2. Professor and Head, Department of Biochemistry, Regional Institute of Medical Sciences, Manipur, India
Description
Category of cardiac dysfunction, severity and follow-up of cardiac diseases are assessed by cardiac function tests mainly. Cardiac disease is referred to any condition which causes inflammation or tissue injury affecting functions of cardiac myocardium. The aim and objective of this study were the estimation of serum calcium and iron parameters among the patients with cardiac disease for the cardiac function test and evaluation of the relationship between serum calcium and iron among men and women as per the age among examined groups. So the aforementioned study was conducted to assess serum calcium, iron, triglycerides and cholesterol status in cardiac diseases. The serum samples were examined for calcium, iron, triglycerides and cholesterol level. The present study shows significantly decreased levels of serum calcium and iron and significantly increased levels of serum triglycerides and cholesterol among different age groups (p<0.001).
Abstract (English)
Category of cardiac dysfunction, severity and follow-up of cardiac diseases are assessed by cardiac function tests mainly. Cardiac disease is referred to any condition which causes inflammation or tissue injury affecting functions of cardiac myocardium. The aim and objective of this study were the estimation of serum calcium and iron parameters among the patients with cardiac disease for the cardiac function test and evaluation of the relationship between serum calcium and iron among men and women as per the age among examined groups. So the aforementioned study was conducted to assess serum calcium, iron, triglycerides and cholesterol status in cardiac diseases. The serum samples were examined for calcium, iron, triglycerides and cholesterol level. The present study shows significantly decreased levels of serum calcium and iron and significantly increased levels of serum triglycerides and cholesterol among different age groups (p<0.001).
Files
IJPCR,Vol16,Issue6,Article376.pdf
Files
(295.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ead852ce92ee5471231270634836765f
|
295.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-05-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue6,Article376.pdf
- Development Status
- Active
References
- 1. Ebner N et al. Iron deficiency in heart failure: a practical guide. Nutrients. 2013 Sep 23; 5(9): 3730-9. 2. John S et al. New insights in the activation of human cholesterol esterase to design potent anti-cholesterol drugs. Mol Divers. 2014 Feb; 18(1): 119-31. 3. Reda S et al. Heart failure and anemia. Herz. 2013 Sep; 38(6): 597-603. 4. Arora NP et al. Iron deficiency anemia in heart failure. Heart Fail Rev. 2013 Jul; 18(4):485- 501. 5. Qaseem A et al. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013 Dec 3; 159(11): 770-9. 6. Gunawardena S et al. Anemia and iron deficiency in heart failure. Curr Heart Fail Rep. 2012 Dec; 9(4): 319-27. 7. Martinez-Quintana E et al. Iron deficiency anemia detection from hematology parameters in adult congenital heart disease patients. Congenit Heart Dis. 2013 Mar-Apr; 8(2): 117-23. 8. Jankowska EA et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail. 2011 Nov; 17(11): 9. 899-906. 10. Santilli G et al. Diagnosis and treatment of anemia in heart failure patients. G Ital Cardiol (Rome). 2011 May; 12(5): 319-26. 11. Klip IT et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013 April; 165(4): 575-582.e3. 12. Zhang W et al. Association of dietary iron intake with mortality from cardiovascular disease; the JACC study. J Epidemiol. 2012; 22(6): 484-93. 13. Zhang T et al. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase Π: friends or foes? Recent Prog Horm Res. 2004; 59: 141-68. 14. Norlin M et al. Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med. 2007 Mar; 7(2): 199-218. 15. Varbo A et al. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated lowdensity lipoprotein cholesterol causes ischemicheart disease without inflammation. Circulation. 2013 Sep 17; 128(12): 1298-309. 16. Jankowska EA et al. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013 Mar; 34(11): 816-29. 17. Kang P et al. Association of total iron binding capacity with coronary artery disease. Clin Chim Acta. 2012 Oct 9; 413(19-20): 1424-9. 18. Von Hachling S et al. Anemia in chronic heart failure: can we treat? Heart Fil Rev. 2012 Mar; 17(2): 203-10. 19. Van Veldhuisen DJ et al. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011 May 31; 8(9):485-93. 20. Rangel I et al. Hypocalcemia is a reversible cause of heart failure. Rev Port Cardiol. 2012 Jan; 31(1): 39-41. 21. Chraibi S et al. Hypo calcemic dilated cardiomyopathy: rare cause of heart failure. Ann Med Interne (Paris). 2001 Nov; 152(7): 483-5. 22. Avsar A ET AL. A rare cause of reversible dilated cardiomyopathy: hypocalcemia. Echocardiography. 004 Oct; 21(7): 609-12. 23. Suzuki T et al. Hypocalcemic heart failure: a reversible form of heart muscle disease. Clin Cardiol. 1998 Mar; 21(3): 227-8. 24. Ari H et al. A rare cause of reversible dilated cardiomyopathy: hypocalcemia. Turk Kardiyol Dern Ars. 2009 Jun; 37(4): 266-8. 25. Verma S et al. Hypocalcemia nutritional rickets: a curable cause of dilated cardiomyopathy. J Trop Pediatr. 2011 Apr; 57(2): 126-8. 26. Brown J et al. Hypocalcemic rickets and dilated cardiomyopathy: case reports and review of literature. K Pediatr Cardiol. 2009 Aug; 30(6): 818-23.